Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Inflammatory Bowel Disease (IBD) is a chronic condition characterized by inflammation in the gastrointestinal tract. It is broadly categorized into two main types: Crohn's Disease (CD) and Ulcerative...
IL-23 inhibitors represent a significant advancement in the treatment landscape for inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC). These biologic agents target...
The relationship between gut inflammation and axial spondyloarthritis (axSpA) has been extensively studied, and the SPARTAKUS cohort plays a key role in advancing our understanding of this association....
Oral lyophilized donor fecal microbiota transplantation (FMT) involves encapsulated, freeze-dried fecal microbiota from a healthy donor, designed for oral administration. This innovative approach simplifies the logistics of FMT...
The real-world study on upadacitinib in patients with moderate-to-severe Crohn’s disease (CD) was conducted across 19 hospitals in the UK between April and October 2023. The study aimed...
Psychological interventions have been increasingly recognized as valuable components in the management of inflammatory bowel disease (IBD). This is because IBD is not only a physical condition but...
The study explored the therapeutic potential of induced pluripotent stem cell-derived CD146+ mesenchymal stem cells (CD146+iMSCs) for treating ulcerative colitis (UC). These stem cells were compared to CD146+...
Decoding Inflammatory Bowel Disease (IBD) progression involves understanding how gut microbiota and host genetic changes correlate with disease severity. A recent study developed a multi-omics framework combining gut...
In the context of perianal fistulizing Crohn's disease (PFCD), ustekinumab (UST) trough concentrations play a critical role in predicting clinical and radiological remission. A recent study has identified...
The novel antibiotic targeting inflammatory bowel disease (IBD) is called enterololin, and it represents a groundbreaking achievement in medical research, combining cutting-edge artificial intelligence (AI) with pharmacological science....
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.